Acoziborole
Acoziborole is an investigational antiparasitic drug being developed for the treatment of human African trypanosomiasis (HAT), also known as sleeping sickness. This disease is caused by the protozoan parasites Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, which are transmitted to humans by the bite of an infected tsetse fly.
Mechanism of Action[edit | edit source]
Acoziborole works by inhibiting the enzyme Trypanosoma brucei adenosine kinase, which is essential for the parasite's survival. By blocking this enzyme, acoziborole disrupts the parasite's ability to synthesize adenosine triphosphate (ATP), leading to its death.
Clinical Development[edit | edit source]
Acoziborole is currently in clinical trials and has shown promise in early studies. It is being developed as an oral treatment, which would be a significant improvement over existing therapies that require intravenous administration. The drug has the potential to simplify the treatment regimen for HAT, making it more accessible to patients in remote areas.
Efficacy and Safety[edit | edit source]
In clinical trials, acoziborole has demonstrated efficacy in clearing the parasite from the bloodstream and central nervous system. The safety profile of the drug is also being closely monitored, with initial results indicating that it is well-tolerated by patients.
Significance[edit | edit source]
The development of acoziborole represents a significant advancement in the fight against neglected tropical diseases. If approved, it could provide a much-needed treatment option for patients suffering from HAT, particularly in sub-Saharan Africa where the disease is most prevalent.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD